212 related articles for article (PubMed ID: 35504807)
41. Autologous peripheral blood stem cell mobilization and collection in patients with lymphoma and multiple myeloma: A single-center experience using the plerixa for pre-emptive approach.
Alsaeed AS; Najib MJ; Al Amoudi SM; Elhemaidi IY; Absi AA; Al Ahmadi MD; Eldadah SK; Rajkhan WA; Khalil MM; Almohammadi MH
Saudi Med J; 2022 Jun; 43(6):626-632. PubMed ID: 35675941
[TBL] [Abstract][Full Text] [Related]
42. Phase 2 trial of intravenously administered plerixafor for stem cell mobilization in patients with multiple myeloma following lenalidomide-based initial therapy.
Kumar SK; Mikhael J; Laplant B; Lacy MQ; Buadi FK; Dingli D; Gertz MA; Laumann K; Miceli T; Mahlman M; Bergsagel LP; Hayman SR; Reeder C; Stewart AK; Dispenzieri A; Gastineau DA; Winters JL
Bone Marrow Transplant; 2014 Feb; 49(2):201-5. PubMed ID: 24185588
[TBL] [Abstract][Full Text] [Related]
43. Pharmacoeconomic impact of up-front use of plerixafor for autologous stem cell mobilization in patients with multiple myeloma.
Kim SS; Renteria AS; Steinberg A; Banoff K; Isola L
Cytotherapy; 2014 Nov; 16(11):1584-1589. PubMed ID: 24927717
[TBL] [Abstract][Full Text] [Related]
44. Steady-state versus chemotherapy-based hematopoietic cell mobilization after anti-CD38-based induction therapy in newly diagnosed multiple myeloma.
Teipel R; Rieprecht S; Trautmann-Grill K; Röllig C; Klötzer C; Zimmer K; Rathaj G; Bach E; Brückner M; Heyn S; Wang SY; Jentzsch M; Schwind S; Kretschmann T; Egger-Heidrich K; Remane Y; Franke GN; von Bonin M; Bornhäuser M; Platzbecker U; Hölig K; Merz M; Vučinić V
Transfusion; 2023 Nov; 63(11):2131-2139. PubMed ID: 37850414
[TBL] [Abstract][Full Text] [Related]
45. Successful hematopoietic stem-cell mobilization with plerixafor plus granulocyte-colony stimulating factor in multiple myeloma patients treated with pomalidomide.
Yoshifuji K; Toya T; Adachi H; Fujita M; Wada A; Konuma R; Kishida Y; Konishi T; Nagata A; Yamada Y; Kaito S; Kumagai T; Inamoto K; Akiyama M; Igarashi A; Najima Y; Doki N; Kobayashi T; Kakihana K; Sakamaki H; Ohashi K
Int J Hematol; 2019 Jul; 110(1):115-118. PubMed ID: 30989487
[TBL] [Abstract][Full Text] [Related]
46. Reduced-dose plerixafor as a mobilization strategy in autologous hematopoietic cell transplantation: a proof of concept study.
Gutiérrez-Aguirre CH; Alvarado-Navarro DM; Palomares-Leal A; Mejía-Jaramillo G; Salazar-Riojas R; León AG; Colunga-Pedraza PR; Sotomayor-Duque G; Jaime-Pérez JC; Cantú-Rodríguez OG; Del Carmen Tarín-Arzaga L; Flores-Jiménez JA; Gómez-Almaguer D
Transfusion; 2019 Dec; 59(12):3721-3726. PubMed ID: 31618456
[TBL] [Abstract][Full Text] [Related]
47. Efficacy and safety of plerixafor for the mobilization/collection of peripheral hematopoietic stem cells for autologous transplantation in Japanese patients with multiple myeloma.
Ri M; Matsue K; Sunami K; Shimazaki C; Hayashi A; Sunaga Y; Sasaki T; Suzuki K
Int J Hematol; 2017 Oct; 106(4):562-572. PubMed ID: 28527129
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of Hematopoietic Stem Cell Mobilization Rates with Early Plerixafor Administration for Adult Stem Cell Transplantation.
Stover JT; Shaw JR; Kuchibhatla M; Horwitz ME; Engemann AM
Biol Blood Marrow Transplant; 2017 Aug; 23(8):1290-1294. PubMed ID: 28411174
[TBL] [Abstract][Full Text] [Related]
49. Impact of daratumumab on stem cell mobilization and collection, engraftment and early post-transplant complications among multiple myeloma patients undergoing autologous stem cell transplantation.
Eleutherakis Papaiakovou E; Terpos E; Kanellias N; Migkou M; Gavriatopoulou M; Ntanasis-Stathopoulos I; Fotiou D; Malandrakis P; Theodorakakou F; Spiliopoulou V; Kostopoulos IV; Tsitsiloni O; Tsirigotis P; Dimopoulos MA; Kastritis E
Leuk Lymphoma; 2023 Dec; 64(13):2140-2147. PubMed ID: 37655597
[TBL] [Abstract][Full Text] [Related]
50. Plerixafor (Mozobil) for stem cell mobilization in patients with multiple myeloma previously treated with lenalidomide.
Micallef IN; Ho AD; Klein LM; Marulkar S; Gandhi PJ; Calandra G; McSweeney PA
Bone Marrow Transplant; 2011 Mar; 46(3):350-5. PubMed ID: 20479709
[TBL] [Abstract][Full Text] [Related]
51. Impairment of filgrastim-induced stem cell mobilization after prior lenalidomide in patients with multiple myeloma.
Popat U; Saliba R; Thandi R; Hosing C; Qazilbash M; Anderlini P; Shpall E; McMannis J; Körbling M; Alousi A; Andersson B; Nieto Y; Kebriaei P; Khouri I; de Lima M; Weber D; Thomas S; Wang M; Jones R; Champlin R; Giralt S
Biol Blood Marrow Transplant; 2009 Jun; 15(6):718-23. PubMed ID: 19450756
[TBL] [Abstract][Full Text] [Related]
52. Pegfilgrastim- versus filgrastim-based autologous hematopoietic stem cell mobilization in the setting of preemptive use of plerixafor: efficacy and cost analysis.
Costa LJ; Kramer C; Hogan KR; Butcher CD; Littleton AL; Shoptaw KB; Kang Y; Stuart RK
Transfusion; 2012 Nov; 52(11):2375-81. PubMed ID: 22404694
[TBL] [Abstract][Full Text] [Related]
53. Cost analysis of a randomized stem cell mobilization study in multiple myeloma.
Varmavuo V; Silvennoinen R; Anttila P; Säily M; Sankelo M; Putkonen M; Ahonen J; Mahlamäki E; Mäntymaa P; Savolainen ER; Remes K; Jantunen E
Ann Hematol; 2016 Oct; 95(10):1653-9. PubMed ID: 27485453
[TBL] [Abstract][Full Text] [Related]
54. Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial.
Gay F; Oliva S; Petrucci MT; Conticello C; Catalano L; Corradini P; Siniscalchi A; Magarotto V; Pour L; Carella A; Malfitano A; Petrò D; Evangelista A; Spada S; Pescosta N; Omedè P; Campbell P; Liberati AM; Offidani M; Ria R; Pulini S; Patriarca F; Hajek R; Spencer A; Boccadoro M; Palumbo A
Lancet Oncol; 2015 Dec; 16(16):1617-29. PubMed ID: 26596670
[TBL] [Abstract][Full Text] [Related]
55. Comparison of two dose levels of cyclophosphamide for successful stem cell mobilization in myeloma patients.
Winkelmann N; Desole M; Hilgendorf I; Ernst T; Sayer HG; Kunert C; Mügge LO; Hochhaus A; Scholl S
J Cancer Res Clin Oncol; 2016 Dec; 142(12):2603-2610. PubMed ID: 27640002
[TBL] [Abstract][Full Text] [Related]
56. Results of a Prospective Randomized, Open-Label, Noninferiority Study of Tbo-Filgrastim (Granix) versus Filgrastim (Neupogen) in Combination with Plerixafor for Autologous Stem Cell Mobilization in Patients with Multiple Myeloma and Non-Hodgkin Lymphoma.
Bhamidipati PK; Fiala MA; Grossman BJ; DiPersio JF; Stockerl-Goldstein K; Gao F; Uy GL; Westervelt P; Schroeder MA; Cashen AF; Abboud CN; Vij R
Biol Blood Marrow Transplant; 2017 Dec; 23(12):2065-2069. PubMed ID: 28797783
[TBL] [Abstract][Full Text] [Related]
57. Feasibility of six cycles of lenalidomide-based triplet induction before stem cell collection for newly diagnosed transplant-eligible multiple myeloma.
Yoshihara S; Yoshihara K; Shimizu Y; Imado T; Takatsuka H; Kawamoto H; Misawa M; Ifuku H; Ohe Y; Okada M; Fujimori Y
Hematology; 2021 Dec; 26(1):388-392. PubMed ID: 34000225
[TBL] [Abstract][Full Text] [Related]
58. Successful "on-demand" plerixafor for autologous peripheral blood stem-cells transplantation for relapsed/refractory germ cell tumors.
Corbingi A; Metafuni E; Di Salvatore M; Putzulu R; Chiusolo P; Schinzari G; Massini G; Rossi E; Zini G; Cassano A; Sica S; Piccirillo N
J Clin Apher; 2022 Feb; 37(1):65-69. PubMed ID: 34822725
[TBL] [Abstract][Full Text] [Related]
59. A comparison of four leukapheresis methods to harvest an optimal dose of CD34+ cells: A single center experience.
Lin Y; Park Y; Khanal A; Campbell-Lee S; Liu L; Chen Z; Patel P; Vidanovic V; Sweiss K; Irene G; Peace D; Rondelli D; Mahmud N
Eur J Haematol; 2022 Dec; 109(6):711-718. PubMed ID: 36030395
[TBL] [Abstract][Full Text] [Related]
60. Benefits of plerixafor for mobilization of peripheral blood stem cells prior to autologous transplantation: a dual-center retrospective cohort study.
Nakamura N; Jo T; Arai Y; Matsumoto M; Sakai T; Tsunemine H; Takaori-Kondo A; Arima N
Cytotherapy; 2023 Jul; 25(7):773-781. PubMed ID: 36914555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
